• Company
• Daiichi Sankyo Korea appoints Jeongtae Kim as new CEO
• by Eo, Yun-Ho Feb 27, 2023 05:57am

• Product
• Daewoong/Novartis promise to cooperate
• by Kim JiEun Feb 27, 2023 05:57am

• Company
• Sales of 26-year-old Gemzar·Zyprexa show rebound
• by Kim, Jin-Gu Feb 27, 2023 05:57am

• Opinion
• [Reporter's view] Implications of Lucentis biosimilar
• by Lee, Tak-Sun Feb 27, 2023 05:57am

• Company
• Will Luxturna will be deliberated by DREC for reimb?
• by Eo, Yun-Ho Feb 27, 2023 05:56am

• Policy
• The value of pharmaceutical bio innovation is reflected
• by Lee, Jeong-Hwan Feb 24, 2023 05:53am

• Opinion
• [Reporter’s View] Decide whether to offer free HCV testing
• by Jung, Sae-Im Feb 24, 2023 05:53am

• Company
• US approval of Celltrion Yuflyma was delayed
• by Feb 24, 2023 05:53am

• Company
• Shingrix may be prescribed in 93 general hospitals in Korea
• by Eo, Yun-Ho Feb 24, 2023 05:52am

• Policy
• Expansion of insurance coverage for diabetes drugs
• by Lee, Tak-Sun Feb 24, 2023 05:52am